Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology:

Younger adults with elevated systolic blood pressure have a higher risk for cardiovascular disease and coronary heart disease than those with normal blood pressure, according to a large long-term study of younger adults published online in the Journal of the American College of Cardiology. The risk was higher for women.

Swedish Medical Center is the first facility in the Rocky Mountain Region to implant a new miniaturized, wireless monitoring sensor to manage heart failure (HF).

Medtronic announced CE (Conformité Européene) mark for the 26 and 29mm sizes of the CoreValve Evolut R System, a next-generation self-expanding valve for transcatheter aortic valve implantation (TAVI) providing the option to recapture and reposition the valve during procedures.

A minimally invasive procedure to repair severe mitral valve regurgitation by clipping together the valve’s leaflets can improve function and quality of life and reduce the risk of hospitalization, research shows.

United States hospitals began using a new medical device from Medtronic plc called the In.Pact Admiral drug-coated balloon (DCB) to treat patients with peripheral arterial disease (PAD) in the upper leg. PAD is a common cardiovascular condition that causes leg pain and increases the risk of heart attack and stroke.

Medtronic announced a partnership agreement between its Cardiocom business and LHC Group.

A new computer program allows doctors to assess blood flow as they are using flow-diverter devices to treat life-threatening aneurysms, suggests a preliminary study being presented at the 27th annual International Symposium on Endovascular Therapy (ISET).